12/16
11:28 pm
lmat
LeMaitre Vascular Prices $150 Million Convertible Senior Notes
Low
Report
LeMaitre Vascular Prices $150 Million Convertible Senior Notes
12/16
08:07 am
lmat
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering [Yahoo! Finance]
Medium
Report
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering [Yahoo! Finance]
12/16
07:57 am
lmat
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering
Medium
Report
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering
12/13
02:06 am
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
12/5
11:05 pm
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
11/25
05:27 pm
lmat
LeMaitre to Participate at Upcoming Investor Conferences in December [Yahoo! Finance]
Low
Report
LeMaitre to Participate at Upcoming Investor Conferences in December [Yahoo! Finance]
11/25
05:20 pm
lmat
LeMaitre to Participate at Upcoming Investor Conferences in December
Low
Report
LeMaitre to Participate at Upcoming Investor Conferences in December
11/25
08:47 am
lmat
Should You Be Adding LeMaitre Vascular (NASDAQ:LMAT) To Your Watchlist Today? [Yahoo! Finance]
Low
Report
Should You Be Adding LeMaitre Vascular (NASDAQ:LMAT) To Your Watchlist Today? [Yahoo! Finance]
11/22
12:31 am
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
11/6
11:09 pm
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
11/2
09:29 am
lmat
LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/1
05:23 pm
lmat
LeMaitre Vascular declares $0.16 dividend [Seeking Alpha]
Low
Report
LeMaitre Vascular declares $0.16 dividend [Seeking Alpha]
11/1
04:47 pm
lmat
LeMaitre to Participate at Upcoming Investor Conferences in November
Low
Report
LeMaitre to Participate at Upcoming Investor Conferences in November
11/1
01:38 pm
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $93.00 price target on the stock, up previously from $90.00.
Medium
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $93.00 price target on the stock, up previously from $90.00.
11/1
11:56 am
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its price target raised by analysts at Barrington Research from $92.00 to $93.00. They now have an "outperform" rating on the stock.
Medium
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its price target raised by analysts at Barrington Research from $92.00 to $93.00. They now have an "outperform" rating on the stock.
10/31
08:35 pm
lmat
LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates [Yahoo! Finance]
Medium
Report
LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates [Yahoo! Finance]
10/31
04:05 pm
lmat
LeMaitre Q3 2024 Financial Results
Medium
Report
LeMaitre Q3 2024 Financial Results
10/15
04:34 pm
lmat
LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024
Low
Report
LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024
10/15
07:57 am
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) is now covered by analysts at Cantor Fitzgerald. They set a "neutral" rating and a $96.00 price target on the stock.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) is now covered by analysts at Cantor Fitzgerald. They set a "neutral" rating and a $96.00 price target on the stock.
9/29
10:17 am
lmat
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Stock Is Going Strong: Is the Market Following Fundamentals? [Yahoo! Finance]
Low
Report
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Stock Is Going Strong: Is the Market Following Fundamentals? [Yahoo! Finance]